# Aldeyra Therapeutics, Inc.: Form 8-K, filed Jul 30, 2026

- Company: [Aldeyra Therapeutics, Inc.](/companies/aldx.md) (CIK 1341235)
- Form: 8-K
- Filed: 2026-07-30
- Accepted by EDGAR: Jul 30, 2026, 17:07 ET
- Period: 2026-07-28
- Accession: 0001193125-26-326337
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341235/000119312526326337/aldx-20260728.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341235/000119312526326337/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1341235/000119312526326337/aldx-20260728.htm

Filed Jul 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-326337. Last ingested by Listed: Nov 6, 2026, 14:45 ET. No prices; not investment advice.